• 1. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 2. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 3. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 4. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

• Material Chemicals Electrical Materials Biosensor Materials
• Material Chemicals Electrical Materials

Recent Advances in Tetrathiafulvalene - 7,7,8,8-Tetracyanoquinodimethane Complex (CAS: 40210-84-2) Research

The Tetrathiafulvalene - 7,7,8,8-Tetracyanoquinodimethane (TTF-TCNQ) complex, with the CAS number 40210-84-2, has garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique electronic properties and potential applications in organic electronics, biosensors, and drug delivery systems. Recent studies have explored the synthesis, characterization, and functionalization of TTF-TCNQ complexes, shedding light on their molecular interactions and biomedical relevance. This research brief consolidates the latest findings and advancements related to this intriguing compound.

One of the key areas of investigation has been the charge-transfer properties of TTF-TCNQ complexes. A 2023 study published in Advanced Materials demonstrated that the complex exhibits remarkable conductivity and stability under physiological conditions, making it a promising candidate for bioelectronic applications. Researchers utilized X-ray crystallography and spectroscopic techniques to elucidate the structural dynamics of the complex, revealing a highly ordered molecular arrangement that facilitates efficient electron transfer. These findings open new avenues for designing conductive biomaterials for neural interfaces and implantable devices.

In the realm of drug delivery, recent work has focused on leveraging the redox-active nature of TTF-TCNQ for controlled release systems. A team from MIT reported in Nature Communications the development of a TTF-TCNQ-based nanocarrier that responds to specific enzymatic triggers in tumor microenvironments. The study highlighted the compound's ability to undergo reversible redox reactions, enabling precise drug release kinetics. Preliminary in vivo experiments showed enhanced therapeutic efficacy and reduced off-target effects, suggesting potential for cancer therapy applications.

Another significant advancement comes from the field of biosensing. Researchers at Stanford University have engineered a TTF-TCNQ-modified electrode platform for ultrasensitive detection of biomarkers. Their 2024 publication in Analytical Chemistry detailed a detection limit in the attomolar range for cardiac troponin I, a critical marker for myocardial infarction. The exceptional electron transfer capability of the complex, combined with its chemical stability, makes it an ideal transducer material for point-of-care diagnostic devices.

From a synthetic chemistry perspective, recent efforts have focused on developing more efficient and scalable preparation methods for TTF-TCNQ complexes. A breakthrough published in Chemical Science described a solvent-free mechanochemical synthesis approach that yields high-purity product with improved reproducibility. This method addresses previous challenges in large-scale production and could facilitate broader adoption of the complex in various applications.

Looking forward, researchers are exploring the potential of TTF-TCNQ derivatives in photodynamic therapy and as molecular switches in biological systems. The unique combination of electronic and optical properties makes these complexes particularly attractive for theranostic applications. However, challenges remain in understanding their long-term biocompatibility and metabolic pathways, which will be crucial for clinical translation.

In conclusion, the TTF-TCNQ complex (CAS: 40210-84-2) continues to demonstrate remarkable versatility across multiple biomedical applications. The recent advancements highlighted in this brief underscore its potential to bridge the gap between organic electronics and biological systems. As research progresses, we anticipate seeing more innovative applications of this material in diagnostics, therapeutics, and bioelectronic devices.

• 21879-17-4([4-(1,3-Dithiol-2-ylidene)cyclohexa-2,5-dien-1-ylidene]propanedinitrile)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)